These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 29905005

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P, Capulli M, Teti A, Galatioto GP, Vicentini C, Chiarugi P, Bologna M, Angelucci A.
    BMC Cancer; 2014 Mar 05; 14():154. PubMed ID: 24597899
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Molecular Testing Identifies Determinants of Exceptional Response and Guides Precision Therapy in a Patient with Lethal, Treatment-emergent Neuroendocrine Prostate Cancer.
    Turina CB, Coleman DJ, Thomas GV, Fung AW, Alumkal JJ.
    Cureus; 2019 Jul 22; 11(7):e5197. PubMed ID: 31565603
    [Abstract] [Full Text] [Related]

  • 25. Selective Actionable and Druggable Protein Kinases Drive the Progression of Neuroendocrine Prostate Cancer.
    Lu C, Qie Y, Liu S, Wu C, Zhang Z, Liu R, Yang K, Hu H, Xu Y.
    DNA Cell Biol; 2018 Sep 22; 37(9):758-766. PubMed ID: 29969286
    [Abstract] [Full Text] [Related]

  • 26. CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC).
    Liu S, Nam HS, Zeng Z, Deng X, Pashaei E, Zang Y, Yang L, Li C, Huang J, Wendt MK, Lu X, Huang R, Wan J.
    bioRxiv; 2024 Mar 31. PubMed ID: 38585861
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of MicroRNAs in Neuroendocrine Prostate Cancer.
    Sreekumar A, Saini S.
    Noncoding RNA; 2022 Mar 30; 8(2):. PubMed ID: 35447888
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer.
    Cheng WC, Wang HJ.
    Tzu Chi Med J; 2021 Mar 30; 33(3):224-232. PubMed ID: 34386358
    [Abstract] [Full Text] [Related]

  • 33. ONECUT2 is a driver of neuroendocrine prostate cancer.
    Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, Puca L, Vosoughi A, Xue H, Li E, Su P, Chen S, Nguyen T, Liang Y, Zhang Y, Xu X, Xu J, Sheahan AV, Ba-Alawi W, Zhang S, Mahamud O, Vellanki RN, Gleave M, Bristow RG, Haibe-Kains B, Poirier JT, Rudin CM, Tsao MS, Wouters BG, Fazli L, Feng FY, Ellis L, van der Kwast T, Berlin A, Koritzinsky M, Boutros PC, Zoubeidi A, Beltran H, Wang Y, He HH.
    Nat Commun; 2019 Jan 17; 10(1):278. PubMed ID: 30655535
    [Abstract] [Full Text] [Related]

  • 34. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
    Yamada Y, Beltran H.
    Curr Oncol Rep; 2021 Jan 12; 23(2):15. PubMed ID: 33433737
    [Abstract] [Full Text] [Related]

  • 35. Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.
    Weissenrieder JS, Reilly JE, Neighbors JD, Hohl RJ.
    Prostate; 2019 Jan 12; 79(1):21-30. PubMed ID: 30106164
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SRRM4 gene expression correlates with neuroendocrine prostate cancer.
    Li Y, Zhang Q, Lovnicki J, Chen R, Fazli L, Wang Y, Gleave M, Huang J, Dong X.
    Prostate; 2019 Jan 12; 79(1):96-104. PubMed ID: 30155992
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
    Coleman DJ, Sampson DA, Sehrawat A, Kumaraswamy A, Sun D, Wang Y, Schwartzman J, Urrutia J, Lee AR, Coleman IM, Nelson PS, Dong X, Morrissey C, Corey E, Xia Z, Yates JA, Alumkal JJ.
    Neoplasia; 2020 Jun 12; 22(6):253-262. PubMed ID: 32403054
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.